OtoScience Labs will be Featured on National TV on Saturday, December 28, 2016
OtoScience Labs, a Jacksonville firm, will be featured Saturday on the Fox Business Channel program Innovations with Ed Begley, Jr.
Jeremy Turner, the company’s co-founder and chief scientist, said “We are excited that Innovations chose to cover OtoScience Labs as a cutting-edge American firm. The crew was here in Jacksonville in August to film the footage that will be used in
the program. We can’t wait to see how it all looks on screen.” The program will be broadcast on the Fox Business Channel (channel 206 on Dish, 359 on Direct TV, and 675 on Mediacom) on Saturday, January 28, 2017 at 4:00 pm CST. It will also air at a
later (to-be- determined) date on the Discovery Channel.
OtoScience Labs is a Jacksonville-based hearing research company that is working to develop the world’s first objective tinnitus measurement system. In this program, Innovations will go into the lab to understand the problem of tinnitus and how
OtoScience Labs’ innovative research is helping to lead the way.
Turner, who is also a professor of psychology at Illinois College, is an internationally-recognized tinnitus researcher. He said, “Tinnitus, or ringing in the ears, is a very common and serious problem that impacts millions of Americans. It is also the most common disability compensation benefit for U.S. military veterans, which makes it an important focus of research for the U.S. Department of Defense.”
Turner continued, “There is no objective measurement for tinnitus, which makes it very difficult to study and treat, similar to how difficult it would be to understand heart disease without an ECG, or to diagnose brain tumors without an MRI.”
OtoScience Labs’ research is being supported by a $1.4 million federal grant from the U.S. Department of Defense’s Psychological Health and Traumatic Brain Injury Program. Turner said the firm’s tinnitus measurement device is being used with
active duty military members and veterans. Local testing of the device is being conducted at SIU School of Medicine in Springfield. Testing will also be conducted at Madigan Army Medical Center in Tacoma, Wash., and at the Veterans Administration Portland Health Care System.
“The results of these studies could enable researchers and medical professionals to move closer to development of a research and diagnostic tool for the study of tinnitus and related hearing problems such as hyperacusis (where sounds seem
louder or more bothersome than they should), and presbycusis (age-related hearing loss),” said Turner.
Innovations, hosted by award winning actor Ed Begley, Jr., is an information-based series geared toward educating the public on the latest breakthroughs in all areas of society. Exploring the latest advancements in science, medicine, and technology
featuring practical solutions and important issues facing consumers and professionals alike. Innovations focuses on cutting-edge advancements in everything from health and wellness to global business, renewable energy, and more.
To learn more about OtoScience Labs visit their website at If you are interested in helping by participating in the firm’s hearing loss and tinnitus research, e-mail , or call 217-243- 8088.
OtoScience Labs’ CEO Elected to American Tinnitus Association’s Scientific Advisory Committee
Jeremy Turner, PhD, has been elected to serve a four-year term on the Scientific Advisory Committee of the American Tinnitus Association (ATA). The ATA was started in 1971 and is the largest nonprofit organization in the US devoted to tinnitus. Their mission is to cure tinnitus through the development of resources that advance tinnitus research. The Scientific Advisory Committee provides technical advice, expert opinions, reviews grant applications and makes funding recommendation to the ATA Board of Directors. For more information about tinnitus or the ATA visit www.ata.org.
OtoScience Labs LLC licenses technology from Southern Illinois University School of Medicine
OtoScience Labs announces it has entered into an agreement with Board of Trustees of Southern Illinois University to acquire the exclusive licensing rights to intellectual property developed at the University’s School of Medicine (US Patents 8,088,077 and 8,888,712). The license allows OtoScience Labs to use, sublicense, and develop the gap-based approach for tinnitus in animal models and humans. The goal is to develop better preclinical screening for ototoxicity and to develop an objective measurement of tinnitus for use in human research and in the clinic.
OtoScience Labs is a biotech company focused on developing solutions for the problems of hearing loss and tinnitus. The company offers noise consulting and contract research services in ototoxicity, and strives to develop better preclinical and clinical tests for hearing loss and tinnitus.
OtoScience Labs, LLC, of Jacksonville, IL has been awarded a $1.4 million Neurosensory Research Award from the U.S. Department of Defense Psychological Health & Traumatic Brain Injury Program.
This grant is being used to test a device for the objective detection of tinnitus, or ringing in the ears, which co-inventors and OtoScience Labs co-founders Jeremy Turner, PhD, and Michael Kinder have developed. The grant brings together OtoScience Labs and a team of scientists and engineers to develop and conduct initial testing of the device. Field testing of the device in active duty military members and veterans will be conducted by our colleagues at Madigan Army Medical Center in Tacoma, WA, and James Henry, PhD, at the VA Portland Health Care System. The results of these studies could enable researchers and medical professionals to move closer to development of a research and diagnostic tool for the study of tinnitus.
The U.S. Centers for Disease Control estimates that 50 million Americans experience tinnitus making it one of the most common health conditions experienced by Americans. For about 1/5 of these people, the symptom is burdensome and disrupts life, and in some cases tinnitus can be disabling and debilitating. Tinnitus is often associated with sleep problems, anxiety, irritability, and concentration problems. These symptoms can produce great personal, social, and financial burden for those suffering, for their families, and for society as whole. Tinnitus is caused by anything that causes hearing loss – most commonly loud noise but also exposure to certain drugs or chemicals. Approximately 30% of marketed medicines have tinnitus as a documented side effect, although usually in a very small percentage of users.
The financial burden of tinnitus is estimated at $26 billion annually by the American Tinnitus Association (www.ata.org). The U.S. Department of Veterans Affairs reports that tinnitus has been the most common service-related disability claim by veterans every year since 2008, resulting in an estimated $1 billion annual cost in disability compensation for tinnitus alone.
For more information on tinnitus visit the American Tinnitus Association or American Speech-Language-Hearing
For more information contact OtoScience Labs at 217-243-8088 or visit www.otosciencelabs.com.